Recombinant TSH Performs as Well as Thyroid Hormone Withdrawal for Iodine-131 Therapy With Dosimetry for Thyroid Cancer
rhTSH is noninferior to THW in preparation for I-131 dosimetry. Compared to THW, rhTSH results in lower calculated allowed I-131 dose after dosimetry, which could translate to fewer side effects or impact on quality of life.
Authors
- C. Carson
- Craig M. Johnson (ORCID: https://orcid.org/0000-0002-4303-090X)
- Dana Awad
- Whitney Goldner (ORCID: https://orcid.org/0000-0002-9724-7987)
- Anery Patel (ORCID: https://orcid.org/0000-0002-7843-5923)
- Frank Rutar
- Abbey Fingeret (ORCID: https://orcid.org/0000-0002-0526-6364)
- Anupam Kotwal (ORCID: https://orcid.org/0000-0002-4500-8546)
- Jarod Hamsa
Institutions
- Nebraska Medical Center (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1210/jendso/bvaf050
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00